Plus Products Partners with CannRx Biosciences to Leverage Proprietary Onset Technology
SAN MATEO, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) — Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) (the “Company” or “PLUS”), a cannabis and hemp branded items business within the U.S., today announced so it has entered into a partnership with CannRx Biosciences (“CannRx”), a leading Israeli cannabis company within the boutique industry of cannabis-based botanical medication, to improve the start of the Company’s items.
CannRx, running from their research lab in Tel Aviv, Israel, has established a nano-particle that is solid soluble technology (“CannTrap”), using proteins to improve the bioavailability of cannabinoids and terpenes. CannRx has replicated the body’s natural and sophisticated transport that is protein-based which facilitates distribution of active substances through your body and tailored this method designed for cannabinoids.
CannRx is led by Dr. William Levine, Founder and Chief Scientific Officer, who was simply selected by Cannabis and technology Today as Innovator of the season in 2019.
PLUS and CannRx want to leverage the patented CannTrap technology to generate items with an increase of managed beginning and offset times during the THC as well as other cannabinoids. The technology has applications across numerous type facets including gummies and beverages, and it is likely to increase formula possibilities across PLUS’s portfolio that is growing reduce the dose needed for desired effect, and increase speed of onset.
PLUS is committed to quality and innovation. The CannRx team is excited about our partnership with PLUS and we look forward to bringing innovative, high quality products to the cannabis market.
Dr. William Levine, Founder and Chief Scientific Officer
“We are excited about the relationship with CannRx and their research team, and the opportunity to further advance the science behind our products,” stated Jake Heimark, CEO and Co-founder of PLUS. “Israel leads the way in cannabis research and the industry is ripe for innovation. We believe that consumers want to take control of how quickly the effects can be felt by them of cannabis. Our objective would be to place them into the driver’s seat for the knowledge, from beginning to end.”
PLUS is a* that is( and cannabis food company focused on using nature to bring balance to consumers’ lives. PLUS’s mission is to make cannabis safe and that is approachable starts with top-notch services and products that deliver consistent customer experiences. PLUS is headquartered in San Mateo, CA.
About CannRx Biosciences
CannRx’s mission would be to develop scientifically-based, proprietary cannabis technologies so that you can produce dependable, repeatable, efficacy products that are driven. CannRx operates in the boutique field of cannabis-based botanical medicine and has developed extensive technology to analyze plant material and understand the bioactivity of the various compounds found within the cannabis plant. Utilizing this technology, CannRx has achieved a range of technological breakthroughs in optimizing* that is( removal distribution and targeted biorelevant formulations. CannRx is driven by the style that all its cannabis items must certanly be “as effective as a drug so that as safe as a product that is natural*)Original press release
Posted by NCV Newswire